Eva Live Inc. filings document material events for an AI-driven digital advertising and marketing technology company. The company’s Form 8-K reports cover product announcements for Eva Brain, NeuroServer, and Fast Quote Direct; Nasdaq listing disclosures; and press-release exhibits describing campaign management, ad-serving, lead-generation, and automation initiatives.
The filing record also includes capital-structure and financing disclosures, including an equity distribution agreement for common stock, a secured convertible note, shelf registration and prospectus-supplement references, and related legal opinions. These disclosures frame GOAI’s public-company reporting around operating results, securities offerings, governance matters, and the funding of its AI advertising platform expansion.
Eva Live Inc. (GOAI) Chief Executive Officer David Boulette purchased 19,800 shares of Common Stock at $2.01 per share on September 25, 2026, in an open market purchase. His reported direct holdings after the transaction were 23,284,225 shares. The amendment corrects the reported post-transaction beneficial ownership amount, which was understated by 18,000 shares in the original Form 4 filed September 28, 2026, due to an error in the number of shares reported in David Boulette's Form 4 filed September 21, 2026. No Rule 10b5-1 plan is reported.
Eva Live Inc (GOAI) Chief Executive Officer David Boulette, also a director and ten percent owner, purchased 18,478 shares of common stock at $2.03 per share on September 22, 2026, in an open-market purchase. He directly held 23,264,425 shares after the transaction, and no Rule 10b5-1 plan is reported for the purchase. The amendment corrects the post-transaction beneficial-ownership amount, which had been understated by 18,000 shares.
Eva Live Inc (GOAI) CEO, director and 10% owner David Boulette reported acquiring 220,947 common shares on June 10, 2026, issued under a board resolution to settle accrued back salary; the reported price was $2.28 per share. On February 17, 2026, he exercised options to acquire 4,000,000 common shares at $0.10 per share, with 16,000,000 options remaining afterward. The amendment corrects the share count from 202,947 in the original report to 220,947.
Eva Live Inc. (GOAI) agreed to issue Dune Equity Holdings LLC a secured note with principal of up to $1,875,000 for a purchase price of up to $1,575,000, including an original issue discount of up to $300,000. Dune funded the first tranche: $937,500 principal for $787,500, yielding $747,500 net after $40,000 withheld for Dune’s legal fees. Eva Live issued 75,000 commitment shares. Dune had not funded the second tranche of $312,500 principal or the third tranche of $625,000 principal as of October 2, 2026; funding is at its discretion while the note is outstanding.
The note carries a one-time 12% interest charge per tranche and matures 12 months after funding; amortization generally begins 15 calendar days after funding and recurs every 30 days at 10% of that tranche’s original total outstanding balance. Dune may convert at $2.50 per share; after an event of default or missed amortization payment, the conversion price is the lesser of $2.50 or 65% of the average of the three lowest traded prices in the prior 10 trading days. Without stockholder approval, shares issuable to Dune are capped at 7,994,828. On default, the amount due is 150% of outstanding principal and accrued interest through repayment. The note is secured and subordinate to Streeterville Capital, LLC’s senior secured debt; proceeds must fund business development and general working capital.
Eva Live Inc (symbol: GOAI) is the issuer of record for a Form 4 filing submitted to the SEC.
Eva Live Inc (symbol: GOAI) is the issuer of record for a Form 8-K filing submitted to the SEC.
Eva Live Inc (GOAI) Chief Executive Officer, director and 10% owner David Boulette purchased 19,800 shares of Common Stock in an open-market transaction on September 25, 2026, at $2.01 per share. He held 23,266,225 shares directly after the purchase. The transaction was not reported under a Rule 10b5-1 plan.
Eva Live Inc. (GOAI) entered an equity purchase agreement with Hudson Global Ventures, LLC. Eva Live may, but is not obligated to, direct purchases of its common stock during the Commitment Period for an aggregate purchase price of up to $10,000,000, at $2.00 per share subject to specified adjustments. Each Put Notice must be at least $15,000 and cannot exceed the lesser of 200% of Average Daily Trading Value or the Applicable Trading Amount. Issuances are capped at 7,994,828 shares, subject to adjustment, unless shareholders approve more under Nasdaq Rule 5635(d).
Eva Live also issued Hudson a warrant for 275,000 shares at $0.01 per share, exercisable beginning September 17, 2026 and expiring September 17, 2031 at 5:00 p.m. Eastern time. Cashless exercise is permitted when the Market Price exceeds the exercise price; the warrant is subject to a 4.99% Beneficial Ownership Limitation and the Exchange Cap, and becomes non-exercisable upon the first occurrence of the common stock being deemed a penny stock on or after September 17, 2026. Eva Live agreed to file an initial resale registration statement within 30 calendar days from the date of the Registration Rights Agreement, covering the maximum securities permitted under SEC rules, beginning with warrant shares.
Eva Live Inc (GOAI) Chief Executive Officer, director and ten-percent owner David Boulette purchased 18,478 shares of common stock in an open-market transaction on September 22, 2026, at $2.03 per share. He directly held 23,246,425 shares following the purchase. No Rule 10b5-1 plan is reported.
Eva Live Inc (GOAI) reports that Chief Executive Officer and director David Boulette exercised 4,000,000 stock options on February 17, 2026 at an exercise price of $0.10 per share under an Executive Stock Options Plan, receiving an equal number of common shares and leaving 16,000,000 options outstanding.
On June 10, 2026, he also acquired 202,947 common shares at $2.28 per share, issued pursuant to a board resolution as compensation for accrued back salary. No Rule 10b5-1 trading plan is reported.